Specimen:
Collect
- One SST
Also Acceptable:
- One Green Top (Li Heparin)
- One Green Top (Na Heparin)
- One Lavender (EDTA)
- One Pink Top (EDTA)
- One Red Top
Submit
- 1 mL (Min:0.5 mL) Serum . Submit Refrigerated. Submit in a Standard Transport Tube.
Also Acceptable:
- 1 mL (Min:0.5 mL) Plasma . Submit Refrigerated. Submit in a Standard Transport Tube.
Special Handling
- Allow specimen to clot completely at room temperature
- Avoid Repeated Freeze/Thaw Cycles
- Serum in SST stable for 48 hours refrigerated.
For patients receiving therapy with high biotin doses (>5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Stability
Ambient: 2 Hour(s); Refrigerated: 14 Day(s); Frozen: 6 Month(s); Incubated: Unacceptable
Methodology
- Electrochemiluminescence Immunoassay (ECLIA)
Performed
Mon-Fri
Reported
1-3 Day(s)
CPT Codes
- 83001
- 83002
Interpretive Data
Please see report for interpretive data.
ADDITIONAL FEMALE FSH REFERENCE RANGES
3.5-12.5 Follicular Phase
4.7-21.5 Ovulation Phase
1.7-7.7 Luteal Phase
25.8-134.8 Postmenopause
ADDITIONAL FEMALE LH REFERENCE RANGES
2.4-12.6 Follicular Phase
14-95.6 Ovulation Phase
1.0-11.4 Luteal Phase
7.7-58.5 Postmenopause
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with at least one test in this panel and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be taken until at least 8 hours after the last biotin administration.
ADDITIONAL FEMALE FSH REFERENCE RANGES
3.5-12.5 Follicular Phase
4.7-21.5 Ovulation Phase
1.7-7.7 Luteal Phase
25.8-134.8 Postmenopause
ADDITIONAL FEMALE LH REFERENCE RANGES
2.4-12.6 Follicular Phase
14-95.6 Ovulation Phase
1.0-11.4 Luteal Phase
7.7-58.5 Postmenopause
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with at least one test in this panel and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be taken until at least 8 hours after the last biotin administration.
Components
- 2166 - FSH
- 2167 - LH
Last Updated: April 23, 2025 @ 5:31 pm
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date. Updated test information can only be guaranteed by using this website.
